Applied BioCode Corp
TWSE:6598
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Applied BioCode Corp
Research & Development
Applied BioCode Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Applied BioCode Corp
TWSE:6598
|
Research & Development
-NT$298.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
Research & Development
-NT$138.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Bionime Corp
TWSE:4737
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Apex Biotechnology Corp
TWSE:1733
|
Research & Development
-NT$157.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-4%
|
|
|
Wellell Inc
TWSE:4106
|
Research & Development
-NT$151.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-5%
|
|
Applied BioCode Corp
Glance View
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
See Also
What is Applied BioCode Corp's Research & Development?
Research & Development
-298.6m
TWD
Based on the financial report for Dec 31, 2025, Applied BioCode Corp's Research & Development amounts to -298.6m TWD.
What is Applied BioCode Corp's Research & Development growth rate?
Research & Development CAGR 5Y
-9%
Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Applied BioCode Corp have been -8% over the past three years , -9% over the past five years .